SCHEMBL26075897

SCHEMBL26075897

COCCOc1ccc(-c2ccc(-c3cc(C)c4cc(P)ccc4n3)cc2F)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SQOR Q9Y6N5 1/20 0.37
▸ PLA2G2A P14555 3/20 0.36
▸ PRKAB2 O43741 1/20 0.36
▸ PRKAG1 P54619 1/20 0.36
▸ PRKAA2 P54646 1/20 0.36
▸ PRKAA1 Q13131 1/20 0.36
▸ PRKAG3 Q9UGI9 1/20 0.36
▸ PRKAG2 Q9UGJ0 1/20 0.36
▸ PRKAB1 Q9Y478 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ ACACA Q13085 1/20 0.34
▸ APP P05067 2/20 0.34
▸ DHODH Q02127 1/20 0.34
▸ MIF P14174 1/20 0.34
▸ RARG P13631 1/20 0.34
▸ AURKA O14965 1/20 0.34
▸ AURKB Q96GD4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075902 0.91 NCF1 (0.37) PLA2G2AALDH1A1CASP1CASP7HSD17B10
SCHEMBL26075867 0.91 PLA2G2A (0.42) PLA2G2AALDH1A1DHODHPDE10A
SCHEMBL26075866 0.91 DHODH (0.43) PLA2G2AACACADHODHPDE10A
SCHEMBL26075327 0.90 SQOR (0.42) SQORPLA2G2APRKAB2PRKAG1PRKAA2
SCHEMBL26075877 0.89 PLA2G2A (0.41) PLA2G2AALDH1A1DHODHPDE10A
SCHEMBL26075885 0.89 HMOX1 (0.41) ALDH1A1HSD17B10ACACAESR1ESR2
SCHEMBL26075868 0.88 PLA2G2A (0.41) PLA2G2AALDH1A1DHODHPDE10APDE2A
SCHEMBL26075878 0.88 PLA2G2A (0.41) PLA2G2AALDH1A1DHODHPDE10APDE2A
SCHEMBL26075882 0.88 MAPT (0.39) PLA2G2AACACADHODHESR1ESR2
SCHEMBL26075880 0.88 PLA2G2A (0.41) PLA2G2AALDH1A1DHODHPDE10APDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD SQOR 255/4885PLA2G2A 1679/4885PRKAB2 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback